A study tracking a new procedure for pancreatic cysts (IPMN)
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study follows patients with a type of pancreatic cyst called IPMN who receive the LINFU procedure, a treatment that uses sound waves and microbubbles. Researchers want to see how well it works and monitor safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old
- You have been diagnosed with IPMN (pancreatic cysts) from any imaging test
- You have had an imaging test like an ultrasound, MRI, or CT within 90 days of the LINFU procedure
- You are able to sign a consent form
- You do not have a known allergy to the contrast agent used in the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special MRI scan and blood tests to see if they can detect early pancreatic cancer in people with high-risk pancreatic cysts called IPMNs. It may help identify cancer earlier, when treatment is more likely to work.
This trial looks for markers in cyst fluid and tissue to help identify which IPMN growths are becoming invasive (spreading). It may help doctors decide who needs surgery.
This study looks at how GLP-1 receptor agonists (medications used for diabetes and weight loss) might affect people with IPMN (a type of pancreatic cyst). The goal is to see if these drugs change the size or growth of the cysts.
This study collects information from people who have an IPMN cyst in the pancreas to help predict who may be at higher risk of pancreatic cancer. It may help your care team estimate risk and plan follow-up more effectively.
This study looks for new markers in the blood or tissues of people with a pancreatic condition called IPMN. The goal is to find better ways to predict if IPMN might turn into cancer and to help choose the best treatment.
This study is testing a new imaging method called LINFU® to see if it can find pancreatic cancer early in people who are at higher risk but have no symptoms. If you are at elevated risk for pancreatic cancer and are already getting imaging tests, this study may help improve early detection.
Hear when a new IPMN, Pancreatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.